InvestorsHub Logo
Followers 32
Posts 10384
Boards Moderated 0
Alias Born 04/20/2016

Re: ronpopeil post# 2808

Thursday, 12/07/2017 9:29:25 AM

Thursday, December 07, 2017 9:29:25 AM

Post# of 5002
There are alot of eyes on VTGN, and despite share price VTGN is watched by big Pharma. For a tiny market cap company they are on many of the biggest Pharmas watch lists. Companies like AGN,J&J,PFE to name a few.

The JP Morgan conference should be very interesting for VTGN next month, now that the patent is locked down and a Phase 2 adjunctive trial is about to begin. Last year they spent quite a bit of time being grilled by J&J guys in a Shark Tank like setting. J&J is developing a ketamine drug. Obviously AGN is already in the game.

This drug could be a multi billion dollar blockbuster, and a new and safe way of treating depression. Most people laugh when I state it could be a $60 to $100 stock, look what just happened to SAGE. Look at past history of the 3 billion dollar market cap hit Alchemy had on a failed depression trial and how quickly it recovered that loss when they redid the trial using the patented method that VTGN is using.

1.5 years is a short time to wait, imo
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VTGN News